← Back to Entity Graph

Australasian Gastro-Intestinal Trials Group

FoundationRegistryHPCABN 34093854267NSW
Relationships
23
Data Sources
2
Revenue
$21.8M
Tax Payable
Preview
Data as of: 15 Mar 2026

About

The Australasian Gastro-Intestinal Trials Group is a nonprofit organisation dedicated to improving health and quality of life for GI cancer patients by developing and conducting clinical trials across Australia. Since 1991, they've conducted 90 research studies providing over 9,930 patients access to promising new treatments. Their mission focuses on advancing treatments for digestive system cancers including esophageal, stomach, liver, pancreatic, bowel, and rectal cancers.

Giving Philosophy

This organisation funds and conducts clinical trials that test new treatments against current standards of care, prioritising research that improves survival rates and quality of life for GI cancer patients. They value collaboration with clinicians, researchers, and community advocates to bring innovative treatments to Australian patients faster.

Wealth Source:Community support through donations, regular giving programs, fundraising events (Gutsy Challenge treks, community fundraisers), and charitable contributions from the public.

Tips for Applicants

As a clinical trials organisation rather than a traditional grantmaker, funding is directed toward their internal trial operations and researcher networks. Researchers interested in collaboration should have established clinical trial experience and connect through their clinical network. Community members can support through donations, fundraising, or participating in their Community Advisory Panel.

Financial History (7 years)

YearRevenueExpensesAssetsSurplus
2023$21.8M$21.0M$30.2M$1.9M
2022$16.7M$17.2M$26.7M$-1,107,601
2021$15.3M$14.3M$23.5M$946K
2020$10.2M$7.3M$17.5M$2.9M
2019$8.4M$9.6M$13.9M$-1,115,397
2018$5.3M$5.8M$13.5M$-454,085
2017$5.8M$7.1M$13.6M$-102,710
Govt Revenue
$751K
Grants Given (AU)
$1.7M
Staff (FTE)
19.6
Volunteers
160
Donations Received
$2.4M

Community Evidence

External Evidence

Identity

GS ID
AU-ABN-34093854267
ABN
34093854267
Sector
health
Financial Year
2023

Focus Areas

Themes
healthresearch
Geography
AU-National
Target Recipients
GI cancer patientsclinical researchersmedical institutionshealthcare professionals
Beneficiaries
General CommunityOtherChronic Illness

Financials

Revenue
$21.8M
Assets
$30.2M

Method

Match Confidence
registry
Cross-references
2 datasets
Match Key
ABN
Relationships
23

Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.

Data Sources

ACNCFoundations

Location Intelligence

Postcode
2050
Locality
Camperdown - Darlington
Remoteness
Major Cities of Australia
SEIFA Disadvantage
Decile 10/10
LGA
Inner West
Entities in Area
152
View on Power Map